Latest news

New clinical, human cardiovascular study on Medox® 26.10.2007
Possible effect on hypertension 18.10.2007
Protective against myelotoxicity 18.10.2007
The Worlds first clinical human study on anthocyanins and its effect on Chronic Inflammation 09.10.2007

Short slide presentation

These slides give a short glance into some of our small molecule drug discovery activities.

Download short slide presentation (PDF)

Biolink Group AS, Hanaveien 4-6, 4327 Sandnes, NORWAY. Telephone +47 4695 2900 mail@biolink.no

CorePublish CMS